Development of a Novel Mouse Anaphylaxis Model Produced by Intermittent Intravenous Injections of Ovalbumin without Adjuvant
スポンサーリンク
概要
- 論文の詳細を見る
This study was performed to develop mouse anaphylaxis model using ovalbumin (OA) as an antigen, with no adjuvant, and an intravenous route of administration. OA at dose levels from 0.5 to 500 mg/kg was injected 3 times into the tail vein of female CD-1 (ICR) mice at 4-day intervals. Clinical signs and extravasation of Evans blue dye (vascular permeability) were observed, serum histamine levels and airway resistance were measured, and histopathological examinations were performed. Furthermore, to detect serum IgE and IgG, heterologous and homologous passive cutaneous anaphylaxis tests were performed. Additionally, strain differences in susceptibility to OA anaphylaxis was examined with 3 mouse strains: ICR, BALB/c and C57BL/6 mice. Shortly after the 3rd injection, most of the animals exhibited systemic anaphylactic signs including death, and this was accompanied by increases in vascular permeability, plasma histamine levels, and airway resistance. Four days after the 2nd injection, anti-OA IgE and IgG were detected in sera of mice injected with 0.5 and 5.0 mg/kg or higher doses of OA, respectively. Histological findings included: congestion in many tissues; detachment of mucosal epithelial cells in the gastrointestinal tract; enhanced death, decreased numbers of lymphocytes, and increased numbers of macrophages in the lymphoid tissues. ICR mice were shown to be most susceptible to the OA anaphylaxis of the 3 mouse strains examined. In conclusion, the results demonstrate that 3 intermittent intravenous injections of OA without adjuvant at 4-day intervals can induce anaphylactic shock in mice, in particular, most effectively in ICR mice, and that the anaphylaxis is characterized by specific IgE and IgG production.
- 日本毒性病理学会の論文
- 2007-12-25
著者
-
Manabe Sunao
Medicinal Safety Research Laboratories, Daiichi Sankyo Co., Ltd.
-
Manabe Sunao
Medicinal Safety Research Laboratories Daiichi Sankyo Co. Ltd.
-
Manabe Sunao
Medical Safety Research Laboratories Sankyo Co. Ltd.
-
Furuhama Kazuhisa
Veterinary Pharmacology Iwate University
-
Kato Michiyuki
Medicinal Safety Research Laboratories Daiichi Sankyo Co. Ltd.
-
TAMANAKA Megumi
Medicinal Safety Research Laboratories, DAIICHI SANKYO CO., LTD.
-
HATTORI Hiroyuki
Medicinal Safety Research Laboratories, DAIICHI SANKYO CO., LTD.
-
AOKI Takashi
Medicinal Safety Research Laboratories, DAIICHI SANKYO CO., LTD.
-
Tamanaka Megumi
Medicinal Safety Research Laboratories Daiichi Sankyo Co. Ltd.
-
Hattori Hiroyuki
Medicinal Safety Research Laboratories Daiichi Sankyo Co. Ltd.
-
Aoki Takashi
Medicinal Safety Research Laboratories Daiichi Sankyo Co. Ltd.
関連論文
- Retroperitoneal Fibromatosis in a Cynomolgus Monkey (Macaca fascicularis)
- Toxicokintic and toxicodynamic analysis of clofibrate based on free drug concentrations in nagase analbuminemia rats (NAR)
- Different responses in mutagenesis induced by quinolone antibacterial agents in two Escherichia coli WP2uvrA/pKM101 strains
- Effect of glutathione (GSH) depletion on DNA damage and blood chemistry in aged and young rats
- Thirteen-week Intravenous Toxicity Study of a Novel Humanized Anti-Human Death Receptor 5 Monoclonal Antibody, CS-1008, in Cynomolgus Monkeys
- CHARACTERIZATION OF RESISTANCE TO BROMOBENZENE-INDUCED HEPATOTOXICITY BY MICROARRAY
- RESISTANCE TO THE SKELETAL MUSCLE INJURY EXPRESSED BY REPEATED TREATMENT WITH COMPOUND A THAT HAS HMG-CoA REDUCTASE INHIBITORY ACTIVITY
- P7-41 Skeletal muscle injury caused by compound A completely recovers in spite of further treatment?(GENERAL TOXICITY)(GENERAL SESSION BY POSTER PRESENTATION)(Proceedings of the 31st Annual Meeting)
- A NOVEL MODEL OF CONTINUOUS DEPLETION OF GLUTATHIONE IN MICE TREATED WITH L-BUTHIONINE (S,R)-SULFOXIMINE
- Involvement of Drug Transporters in the Acquired Resistance to Bromobenzene-induced Hepatotoxicity (LIVER/DIGESTIVE SYSTEM) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th Annual Meeting)
- Circadian modulation of hepatic transcriptome in transgenic rats expressing human growth hormone
- Acquired Resistance to Bromobenzene Hepatotoxicity by Repeated Treatment of Rats with Bromobenzene
- EFFECT OF TROGLITAZONE ON THE LIVER OF A GUNN RAT MODEL OF GENETIC ENZYME POLYMORPHISM
- Collaborative work on evaluation of ovarian toxicity : 8) Two- or four-week repeated-dose studies and fertility study of Anastrozole in female rats
- Age-Related Changes in Thyroid Lesions and Function in F344/DuCrj Rats
- Decrease in protein binding and its effect on toxicokinetics (TK)/toxicodynamics (TD) of diclofenac and propranolol in pregnant rats
- Toxicogenomic Biomarkers for Liver Toxicity
- Effect of feeding condition on gene expression analysis using DNA chip.(GENERAL SESSION BY POSTER PRESENTATION)(MOLECULAR TOXICITY & TOXICOGENOMICS)
- Gene expression analysis on rat livers treated with L-buthionine (S, R)-sulfoximine : investigation of data compatibility between RG U34A and RAE 230A GeneChips(Toxicogenomics, Toxicoproteomics, Proceedings of the 32nd Annual Meeting)
- Gene expression analysis in rat livers and immune organs treated with isoniazid, phenytoin, hydralazine hydrochloride or chlorpromazine(Proceedings of the 32nd Annual Meeting)
- P6-47 Relationship between hepatic glutathione content and gene expression profile in F344 male rats treated with L-Buthionine(S,R)-sulfoximine(TOXICOGENOMICS)(GENERAL SESSION BY POSTER PRESENTATION)(Proceedings of the 31st Annual Meeting)
- Gene expressions in F344 rat livers treated with acetaminophen or cycloheximide (TOXICOGENOMICS AND TOXICOPROTEOMICS) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th Annual Meeting)
- Effect of aging on gene expression profile in rat livers treated with phenobarbital or clofibrate (TOXICOGENOMICS AND TOXICOPROTEOMICS) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th Annual Meeting)
- Osteosarcomas in the Lungs of an ICR Mouse
- RENAL EFFECTS OF 26-WEEK ADMINISTRATION OF OLMESARTAN MEDOXOMIL/HYDROCHLOROTHIAZIDE IN RATS
- Analysis of nephropathy using DNA chip.(GENERAL SESSION BY POSTER PRESENTATION)(MOLECULAR TOXICITY & TOXICOGENOMICS)
- Gene Expression Analysis on the Rat Liver Treated with Clofibrate or Phenobarbital.(GENERAL SESSION BY POSTER PRESENTATION)(MOLECULAR TOXICITY & TOXICOGENOMICS)
- Immunohistochemical Staining Methods for Connexin32 on Formalin-Fixed Paraffin-Embedded Sections
- "C-15 Effect of sodium supplementation on CS-866 repeated-dose toxicity study on rats.
- Pulmonary Histiocytic Sarcoma in Two Aged Dogs of a Beagle Colony
- Relationship between hepatocellular apoptosis and Kupffer cell activation in the livers of rats treated with cycloheximide(Proceedings of the 32nd Annual Meeting)
- Toxicogenoimics, Proteomics and Metabonomics(Toxicity Screening Strategy in Early Stage Drug Development : Current Situation and Perspective, Proceedings of the 32nd Annual Meeting)
- Comparison of Age-Related Bone Changes between Mini Rats and Wistar Rats
- Bronchioloalveolar Carcinoma in an Aged Beagle Dog
- Toxicogenomics coupled with proteomics for investigation of drug metabolizing enzymes (WORKSHOP3: CURRENT ISSUES IN PROTEOMICS AND TOXICOGENOMICS) (Proceedings of the 30th Annual Meeting)
- Sex and circadian modulatory effects on rat liver as assessed by transcriptome analyses
- Bronchioloalveolar Carcinoma in an Aged Beagle Dog
- Periodical Examinations of Ethylnitrosoureainduced Mutations in the Liver and Small Intestine of MutaMouse.(GENERAL SESSION BY POSTER PRESENTATION)(GENOTOXICITY)
- Chondrotoxicity of Quinolone Antimicrobial Agents
- Aggravation of Galactosamine Hepatotoxicity by Albumin in Rats
- Development of a Novel Mouse Anaphylaxis Model Produced by Intermittent Intravenous Injections of Ovalbumin without Adjuvant
- Cerivastatin induces type-I fiber-, not type-II fiber-, predominant muscular toxicity in the young male F344 rats
- Present Situation of Toxicogenomics : Application of Gene-Expression Data to Safety Evaluation of Chemicals.(WORKSHOP 3 : TOXICOGENOMICS AND MOLECULAR TOXICOLOGY)
- S6-1 What Are Idiosyncratic Drug Reactions(SYMPOSIUM 6: IDIOSYNCRATIC DRUG REACTIONS)(Proceedings of the 31st Annual Meeting)
- Thirteen-week Intravenous Toxicity Study of a Novel Humanized Anti-Human Death Receptor 5 Monoclonal Antibody, CS-1008, in Cynomolgus Monkeys
- Effect of glutathione (GSH) depletion on DNA damage and blood chemistry in aged and young rats
- Toxicogenomic Biomarkers for Liver Toxicity
- Evaluation of canine T-cell dependent antibody response to the primary and secondary immunization with keyhole limpet hemocyanin